InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Daniel O'Day. Director active across 1 company, notably Gilead Sciences, INC.. In total, 1 reports have been published. History available since 3 August 2026. The latest transaction was disclosed on 3 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration